The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAukett Swanke Regulatory News (AUK)

Share Price Information for Aukett Swanke (AUK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.55
Bid: 1.40
Ask: 1.70
Change: 0.00 (0.00%)
Spread: 0.30 (21.429%)
Open: 1.55
High: 1.55
Low: 1.55
Prev. Close: 1.55
AUK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

11 May 2017 16:14

RNS Number : 9229E
Aukett Swanke Group PLC
11 May 2017
 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014

 

Aukett Swanke Group Plc

 

Period end trading update

 

Aukett Swanke Group Plc (the "Group") the international group of architects, interior designers and engineers, today provides an update on trading for the first six months (to 31 March 2017) of the current financial year.

In our 2016 year end report published on 12 January 2017 we predicted a decline in United Kingdom ("UK") revenues being offset by an improvement in the United Arab Emirates ("UAE"). This trend has largely persisted during the six months to 31 March 2017, with the UK producing a net loss for the period and the UAE trading profitably after recovering previous trading losses. However, the results from the UAE have also been impacted by late bad debt provisions such that the combined half year result of the UK and UAE are now expected to be an overall loss.

Our Continental European operations were expected to be in profit for the period. However, both our Turkish and Berlin businesses are now expected to produce much lower results due to a major project cancellation in Istanbul (in advance of the Referendum); ongoing delays as a result of the State of Emergency in Turkey; and a delay on a significant project in Berlin. The combination of these factors has reversed what was expected to be a profitable situation.

As a result of all of the above the Board now expects a loss for the first half, which will be partly mitigated by an adjustment to the deferred consideration payable in respect of the acquisition of Shankland Cox Limited. Encouragingly cash at the half year stood at £1.56m (30 September 2016: £1.84m) and net funds at £600k (30 September 2016: £790k). We expect to release our interim results in the week commencing 19 June 2017.

 

Enquiries

 

Aukett Swanke Group Plc - 020 7843 3000

 

Nicholas Thompson, Chief Executive Officer

Beverley Wright, Chief Financial Officer

 

FinnCap 020 7220 0500

 

Corporate Finance: Julian Blunt/Giles Rolls

Corporate Broking: Alice Lane

 

Investor/Media enquiries

 

Ben Alexander 07926 054111

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSFFFIFFWSEFI
Date   Source Headline
4th Apr 20247:00 amRNSSubscription Update & Director/PDMR Notifications
28th Mar 202411:52 amRNSHolding(s) in Company
28th Mar 20247:00 amRNSFinal Results and Notice of AGM
27th Mar 202412:04 pmRNSHolding(s) in Company
27th Mar 202412:03 pmRNSHolding(s) in Company
21st Mar 20247:00 amRNSAcquisition, Subscription and Notice of Results
19th Feb 20247:00 amRNSArtificial Intelligence Consortium
14th Feb 202410:40 amRNSHolding(s) in Company
2nd Feb 20247:00 amRNSCommercial Update
4th Jan 20247:00 amRNSHolding(s) in Company
27th Dec 20237:00 amRNSLaunch of Employee Share Purchase Plans
17th Nov 20232:32 pmRNSHolding(s) in Company
14th Nov 20239:02 amRNSHolding(s) in Company
18th Oct 20237:00 amRNSAcquisition of TR Control Solutions Limited
10th Oct 202311:15 amRNSHolding(s) in Company
5th Oct 202312:01 pmRNSProperty marketed for sale
17th Jul 20237:00 amRNSAcquisition of Anders+Kern U.K. Limited
27th Jun 20237:05 amRNSAppointment of Chief Operating Officer
27th Jun 20237:00 amRNSInterim Results
27th Apr 20231:20 pmRNSHolding(s) in Company
24th Apr 20237:00 amRNSAppointment of Non-Executive Director
21st Apr 202311:45 amRNSResult of AGM and Board Changes
5th Apr 20233:15 pmRNSPosting of Notice of AGM and Annual Report
4th Apr 20237:00 amRNSDisposal of Live Events Business
28th Mar 20237:00 amRNSResults for the year ended 30 September 2022
21st Mar 20237:00 amRNSResult of GM, Board Change, Acquisition Completion
2nd Mar 20237:00 amRNSProposed Acquisition, Rule 9 Waiver and GM Notice
1st Feb 20234:53 pmRNSChange of Adviser
30th Jan 20234:37 pmRNSHolding(s) in Company
8th Dec 202212:40 pmRNSBoard Changes
17th Nov 20229:00 amRNSHolding(s) in Company
5th Oct 20223:15 pmRNSHolding(s) in Company
6th Sep 20227:00 amRNSHolding(s) in Company
2nd Sep 202211:20 amRNSHolding(s) in Company
16th Aug 20227:00 amRNSHolding(s) in Company
4th Aug 20223:27 pmRNSHolding(s) in Company
4th Aug 20223:24 pmRNSHolding(s) in Company
25th Jul 202210:53 amRNSCompletion of Nominated Adviser Due Diligence
29th Jun 20227:00 amRNSInterim Results
7th Jun 20226:00 pmRNSHolding(s) in Company
29th Apr 20227:00 amRNSSale of John R Harris & Partners Limited
29th Apr 20227:00 amRNSSale of John R Harris & Partners Limited
28th Apr 20227:00 amRNSAppointment of Nominated Adviser
26th Apr 20227:00 amRNSAnnouncement of results of AGM
11th Apr 20227:00 amRNSHolding(s) in Company
31st Mar 20227:00 amRNSAnnouncement of final results for the year end
28th Feb 20228:45 amRNSHolding(s) in Company
30th Jun 20217:00 amRNSGrant of Options to a director
29th Jun 20217:00 amRNSInterim results
29th Mar 20212:47 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.